ArticleFrontiers in pharmacology2021

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.

Fei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.